(Q28186603)

GOA release 2020-03-11

author

Kari Alitalo

12

0 references

Michael Jeltsch

7

0 references

Christer Betsholtz

11

0 references

Juha Partanen

Juha Partanen

4

0 references

Heikki Rauvala

Heikki Rauvala

10

0 references

David G Jackson

David G Jackson

8

0 references

Tatiana V Petrova

6

Tatiana V Petrova

0 references

author name string

Marika J Karkkainen

1

0 references

Paula Haiko

2

0 references

Kirsi Sainio

3

0 references

Jussi Taipale

5

0 references

Marja Talikka

Signaling pathways in vascular development

9

0 references

language of work or name

English

0 references

publication date

January 2004

0 references

published in

Nature Immunology

0 references

volume

5

0 references

page(s)

74-80

0 references

issue

1

0 references

cites work

1 reference

7 January 2021

Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin

1 reference

7 January 2021

Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs

1 reference

7 January 2021

Organogenesis of lymphoid tissues

1 reference

7 January 2021

The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues.

1 reference

7 January 2021

On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig

1 reference

7 January 2021

The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature

1 reference

7 January 2021

Prox1 function is required for the development of the murine lymphatic system

1 reference

7 January 2021

An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype

1 reference

7 January 2021

Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor

1 reference

7 January 2021

Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate

1 reference

7 January 2021

Cardiovascular failure in mouse embryos deficient in VEGF receptor-3

1 reference

7 January 2021

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

1 reference

7 January 2021

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

1 reference

7 January 2021

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

1 reference

7 January 2021

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

1 reference

7 January 2021

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

1 reference

7 January 2021

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

1 reference

7 January 2021

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

1 reference

7 January 2021

Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes

1 reference

7 January 2021

Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers

1 reference

7 January 2021

Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium

1 reference

7 January 2021

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium

1 reference

7 January 2021

T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema

1 reference

7 January 2021

The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man

1 reference

7 January 2021

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

7 January 2021

Embryonic expression pattern of the murine figf gene, a growth factor belonging to platelet-derived growth factor/vascular endothelial growth factor family.

1 reference

7 January 2021

A model for gene therapy of human hereditary lymphedema

1 reference

7 January 2021

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

1 reference

7 January 2021

Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

1 reference

7 January 2021

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

7 January 2021

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

1 reference

7 January 2021

Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia

1 reference

7 January 2021

Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect

1 reference

7 January 2021

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

1 reference

7 January 2021

The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells.

1 reference

7 January 2021

A tumor-homing peptide with a targeting specificity related to lymphatic vessels

1 reference

7 January 2021